256 related articles for article (PubMed ID: 17261770)
1. Sex hormones and risk of liver tumor.
Giannitrapani L; Soresi M; La Spada E; Cervello M; D'Alessandro N; Montalto G
Ann N Y Acad Sci; 2006 Nov; 1089():228-36. PubMed ID: 17261770
[TBL] [Abstract][Full Text] [Related]
2. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology.
Maillette de Buy Wenniger L; Terpstra V; Beuers U
Dig Surg; 2010; 27(1):24-31. PubMed ID: 20357448
[TBL] [Abstract][Full Text] [Related]
3. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
5. Gender disparity of hepatocellular carcinoma: the roles of sex hormones.
Yeh SH; Chen PJ
Oncology; 2010 Jul; 78 Suppl 1():172-9. PubMed ID: 20616601
[TBL] [Abstract][Full Text] [Related]
6. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
8. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and hepatocellular carcinoma.
Blonski W; Reddy KR
Clin Liver Dis; 2008 Aug; 12(3):661-74, x. PubMed ID: 18625433
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases.
Bayan K; Yilmaz S; Tuzun Y; Yildirim Y
Hepatogastroenterology; 2007 Dec; 54(80):2198-202. PubMed ID: 18265632
[TBL] [Abstract][Full Text] [Related]
11. Fetal and neonatal hepatic tumors.
Isaacs H
J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
[TBL] [Abstract][Full Text] [Related]
12. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
16. Role of alcohol in liver carcinogenesis.
McKillop IH; Schrum LW
Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic.
Voiculescu M; Winkler RE; Moscovici M; Neuman MG
J Gastrointestin Liver Dis; 2008 Sep; 17(3):315-22. PubMed ID: 18836626
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.
Farinati F; Cardin R; Bortolami M; Burra P; Russo FP; Rugge M; Guido M; Sergio A; Naccarato R
J Viral Hepat; 2007 Dec; 14(12):821-9. PubMed ID: 18070284
[TBL] [Abstract][Full Text] [Related]
20. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
